Cytotoxic T cells expressing the CD8 cell‐surface marker are the most powerful effectors associated with the cancer immune response,42 but in the TME, tissue‐resident memory CD8+ T cells may express various dysfunctional markers, such as PDCD1 and CTLA443; these markers have also been included. This evidence concerns the gene CD8A and cancer.